Neuro-Oncology Reviews

Volume 25 Number 18
30 September 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 18, 30 Sptember

Park YW, Vollmuth P, Foltyn-Dumitru M, Sahm F, Choi KS, Park JE, Ahn SS, Chang JH, Kim SH.
The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors.
J Magn Reson Imaging. 2023 Sep 16
. doi: 10.1002/jmri.29016. PMID: 37715567. Review. ˍ

Rabah N, Ait Mohand FE, Kravchenko-Balasha N.
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers.
Int J Mol Sci. 2023 Sep 19;24(18):14256
. doi: 10.3390/ijms241814256. PMID: 37762559. Review. ˍ

van den Bent MJ, Geurts M, French PJ, Smits M, Capper D, Bromberg JEC, Chang SM.
Primary brain tumours in adults.
Lancet. 2023 Sep 19:S0140-6736(23)01054-1
. doi: 10.1016/S0140-6736(23)01054-1. PMID: 37738997. Review˰ ˍ


Harrison DJ, Wu E, Singh R, Ghaith S, Suarez-Meade P, Brown NJ, Sherman WJ, Robinson MT, Lin MP, Lawton MT, Quinones-Hinojosa A.
Primary and Specialist Palliative Care in Neurosurgery: A Narrative Review and Bibliometric Analysis of Glioblastoma and Stroke.
World Neurosurg. 2023 Sep 20:S1878-8750(23)01316-5
. doi: 10.1016/j.wneu.2023.09.048. PMID: 37739173. Review, Bibliometric analysis˰ ˍ

Li X, Wang J, Yuan G, Pan Y.
Efficacy of TTFields in high-grade gliomas: a protocol for systematic review and meta-analysis.
BMJ Open. 2023 Sep 20;13(9):e073753
. doi: 10.1136/bmjopen-2023-073753. PMID: 37730390. Review, Meta-analysis. ˍ

Winter SF, Vaios EJ, Shih HA, Grassberger C, Parsons MW, Gardner MM, Ehret F, Kaul D, Boehmerle W, Endres M, Dietrich J.
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy.
Curr Treat Options Oncol. 2023
Sep 20. doi: 10.1007/s11864-023-01131-x. PMID: 37728819. Review˰ ˍ

Marwah R, Xing D, Squire T, Soon YY, Gan HK, Ng SP.
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity.
J Neurooncol. 2023
Sep 21. doi: 10.1007/s11060-023-04441-0. PMID: 37733174. Review, Meta-analysis. ˍ

Ng S, Duffau H, Herbet G.
Perspectives in human brain plasticity sparked by glioma invasion: from intraoperative (re)mappings to neural reconfigurations.
Neural Regen Res. 2023 Sep 22, 2024;19(5):947-948. doi: 10.4103/1673-5374.382246. PMID: 37862182. Perspective. ˍ

Gan X, Liu Y, Wang X.
Targeting androgen receptor in glioblastoma.
Crit Rev
Oncol Hematol. 2023 Sep 24;191:104142. doi: 10.1016/j.critrevonc.2023.104142. PMID: 37742885. Review. ˍ

Bhatia S, Tonorezos ES, Landier W.
Clinical Care for People Who Survive Childhood Cancer: A Review.
JAMA. 2023 Sep 26;330(12):1175-1186
. doi: 10.1001/jama.2023.16875. PMID: 37750876. Review˰ ˍ

Pan I, Huang RY.
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?
Curr Opin Neurol. 2023 Sep 26;36(6):549-556. doi: 10.1097/WCO.0000000000001213. PMID: 37973024. Review˰

Rhee JY, Strander S, Podgurski A, Chiu D, Brizzi K, Forst DA.
Palliative Care in Neuro-oncology: an Update.
Curr Neurol Neurosci Rep. 2023 Sep 26
. doi: 10.1007/s11910-023-01301-2. PMID: 37751050. Review˰ ˍ

Trivedi R, Bhat KP.
Liquid biopsy: creating opportunities in brain space.
Br J Cancer. 2023 Sep 26
. doi: 10.1038/s41416-023-02446-0. PMID: 37752289. Review˰ ˍ

Waite KA, Cioffi G, Malkin MG, Barnholtz-Sloan JS.
Disease-Based Prognostication: Neuro-Oncology.
Semin Neurol. 2023 Sep 26
. doi: 10.1055/s-0043-1775751. PMID: 37751857. Review˰ ˍ

Zoi V, Giannakopoulou M, Alexiou GA, Bouziotis P, Thalasselis S, Tzakos AG, Fotopoulos A, Papadopoulos AN, Kyritsis AP, Sioka C.
Nuclear Medicine and Cancer Theragnostics: Basic Concepts.
Diagnostics (Basel). 2023 Sep 26;13(19):3064. doi: 10.3390/diagnostics13193064. PMID: 37835806. Review.

Jain P, Vashist S, Panjiyar BK.
Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression.
Cureus. 2023 Sep 27;15(9):e46089. doi: 10.7759/cureus.46089. PMID: 37900496. Review.

Muoio B, Espeli V, Treglia G.
Neuro-Oncology and Positron Emission Tomography: "Just Can't Get Enough".
Cancers (Basel). 2023 Sep 27;15(19):4739. doi: 10.3390/cancers15194739. PMID: 37835432. Editorial.

Aydemir E, Arslan İİ, Görkay AH.
The Application of Electromagnetic Fields in Cancer.
Adv Exp Med Biol. 2023 Sep 28
. doi: 10.1007/5584_2023_788. PMID: 37755661. Review˰ ˍ

Bartusik-Aebisher D, Serafin I, Dynarowicz K, Aebisher D.
Photodynamic therapy and associated targeting methods for treatment of brain cancer.
Front Pharmacol. 2023 Sep 28;14:1250699. doi: 10.3389/fphar.2023.1250699. PMID: 37841921. Review.


Pasqualetti F, Miniati M, Gonnelli A, Gadducci G, Giannini N, Palagini L, Mancino M, Fuentes T, Paiar F.
Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
Biology (Basel). 2023 Sep 28;12(10):1295. doi: 10.3390/biology12101295. PMID: 37887005. Review.

Pertichetti M, Corbo D, Belotti F, Saviola F, Gasparotti R, Fontanella MM, Panciani PP.
Neuropsychological Evaluation and Functional Magnetic Resonance Imaging Tasks in the Preoperative Assessment of Patients with Brain Tumors: A Systematic Review.
Brain Sci. 2023 Sep 28;13(10):1380. doi: 10.3390/brainsci13101380. PMID: 37891749. Review.

Price M, Ryan K, Shoaf ML, Neff C, Iorgulescu JB, Landi DB, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS, Ostrom QT.
Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015-2019.
Neurooncol Pract. 2023 Sep 28;11(1):5-25. doi: 10.1093/nop/npad061. PMID: 38222052. Review. ˍ

Dal Bello S, Martinuzzi D, Tereshko Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M.
The Present and Future of Optic Pathway Glioma Therapy.
Cells. 2023 Sep 29;12(19):2380. doi: 10.3390/cells12192380. PMID: 37830595. Review.

De Vito A, Ben Zvi I, D'Arco F.
MR Protocols for Paediatric Neurosurgical Common Conditions: An Update Guide for Neurosurgeons.
Adv Tech Stand Neurosurg.
2023 Sep 29;48:57-72. doi: 10.1007/978-3-031-36785-4_3. PMID: 37770681. Review˰ ˍ

Song KW, Wen PY.
Novel trial designs in neuro-oncology.
Curr Opin Neurol. 2023 Sep 29. doi: 10.1097/WCO.0000000000001210. PMID: 37865854. Review˰

Teske N, Tonn JC, Karschnia P.
How to evaluate extent of resection in diffuse gliomas: from standards to new methods.
Curr Opin Neurol. 2023 Sep 29. doi: 10.1097/WCO.0000000000001212. PMID: 37865849. Review˰

Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM, Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE, Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM.
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
J Clin Oncol. 2023 Sep 29:JCO2301059
. doi: 10.1200/JCO.23.01059. PMID: 37774317. Guidelines˰ ˍ

Wen PY, van den Bent M, Vogelbaum MA, Chang SM.
RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) Criteria for High- and Low-Grade Glial Tumors in Adults Designed for the Future.
Neuro Oncol. 2023 Sep 29:noad189
. doi: 10.1093/neuonc/noad189. PMID: 37774741. Editorial˰ ˍ
Refers to: Wen PY, et al., RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
J Clin Oncol. 2023 Sep 29:JCO2301059
. doi: 10.1200/JCO.23.01059. PMID: 37774317. Guidelines˰ ˍ

Yakubov E, Ghoochani A, Savaskan N.
Editorial: Ferroptosis in malignant brain tumors.
Front Oncol. 2023 Sep 29;13:1276971∟. doi: 10.3389/fonc.2023.1276971. PMID: 37841440. Editorial.

Alsulami TA, Hyare H, Thomas DL, Golay X.
The value of arterial spin labelling (ASL) perfusion MRI in the assessment of post-treatment progression in adult glioma: A systematic review and meta-analysis.
Neurooncol Adv. 2023 Sep 30;5(1):vdad122. doi: 10.1093/noajnl/vdad122. PMID: 37841694. Review, Meta-analysis.